Several studies observed greater levels of IL-33 and ST2 expression in CRC tissues compared with adjacent normal tissues [73,74,75,79,82], as well as in CRC patients compared with healthy volunteers [75]. The gene discussed is IL33; the disease is colorectal carcinoma.